查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197851

骨科生物材料市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Orthopedic Biomaterials Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

骨科生物材料市場預計在 2022-2027 年的預測期內復合年增長率為 7.5%。

由於 2020 年全國封鎖，私人和公共交通受到限制，減少了交通事故和傷害。 因此，醫療機構的重點從手術轉移到 COVID-19 患者，這在大流行的早期階段對市場產生了短期影響，特別是在專科醫院。 此外，世界各地的骨科中心和醫院已經關閉或在資源有限的情況下運營，其他醫院已轉變為收容設施和治療 COVID-19 患者的單位。 例如，2020 年 8 月發表的一篇題為“Impact of COVID-19 in Orthopaedic Surgery. Experience from Saudi Arabia”的研究論文指出，骨科住院醫師培訓因 COVID-19 大流行而增加。 所有擇期手術的不可避免的暫停限制了一些程序的實踐和經驗。 因此，這些因素在 COVID-19 大流行期間對骨科生物材料的需求產生了重大影響。

此外，運動損傷的增加、意外創傷病例數的增加以及關節重建和關節成形術等骨科手術的增加也對骨科生物材料產生了大量需求。我們正在推動增長的材料市場。

老年人口的增長、肌肉骨骼損傷發生率的增加以及選擇膝關節置換、結構和其他關節相關骨科手術的患者數量的增加預計將推動市場增長。預計。 根據聯合國經濟和社會事務部《世界老齡化人口：2020 年亮點》，2020 年 65 歲及以上人口將達到 7.27 億，預計到 2050 年將翻一番，達到 15 億。 隨著世界範圍內越來越多的老年人口變得更容易出現關節問題，從而更容易發生手術，預計未來幾年骨科□□生物材料的採用將會增加。 此外，根據世界衛生組織 2022 年 7 月的更新，全球約有 17.1 億人患有肌肉骨骼疾病。 如此高的肌肉骨骼疾病負擔導致肌肉骨骼損傷的增加，這推動了骨科生物材料的市場增長。

此外，該領域的進展也在推動市場增長。 例如，2020 年 9 月，贏創為醫療技術市場開發了一種新型骨傳導聚醚醚酮 (PEEK)，可改善骨植入物融合。

因此，上述因素預計將在整個分析期間推動市場增長。 然而，缺乏與該程序相關的報銷政策可能會在一定程度上阻礙市場增長。

骨科生物材料的市場趨勢

骨科生物材料的陶瓷&生物活性玻璃板塊未來有望實現健康增長。

按材料類型劃分的陶瓷和生物活性玻璃細分市場預計未來將呈現健康增長。 這是由於越來越多地採用脊柱手術和椎間融合術。 此外，融合手術中合成融合器和椎弓根螺釘的興起正在推動這一領域的增長。 合成融合器和椎弓根螺釘可維持符合條件的患者的穩定性並提高同種異體移植物融合率。

多項體外和體內研究評估了陶瓷和生物活性玻璃作為骨科生物材料的改進生物相容性、生物降解性和骨整合。 例如，在 2020 年 2 月 BMC（S□□pringer Nature 的一部分）上發表的論文“骨科生物材料：免疫調節的過去和未來”中，第一代陶瓷與週期性組件損壞有關。然而，在韓國，第二代新一代生物惰性陶瓷，即氧化鋯增強氧化鋁，已被廣泛使用，並在很大程度上取代了超高分子量聚乙烯（UHMWPE），成為全髖關節置換術的首選材料。據說有 這些材料有望始終用於關節置換手術。 因此，骨科手術中陶瓷的高效率和玻璃材料的生物利用度有望推動這一領域的增長。

此外，2022 年 2 月，Orthofix Medical 推出了 Opus BA，這是一種合成的生物活性骨移植液，混合了碳酸磷灰石骨礦物質、生物活性玻璃和 1 型膠原蛋白載體，用於頸椎和腰椎融合手術。。 作為支架，Opus BA 允許骨骼在表面生長，並在癒合過程中被吸收以替代天然骨骼。 此類發布正在推動細分市場的增長。

因此，由於上述因素，市場預計在預測期內會出現增長。

北美佔據了很大的市場份額，預計在預測期內也會如此

北美是全球骨科生物材料市場的主要參與者，因為其目標人群不斷增長，人口老齡化速度加快，與骨科相關的先進產品採用率高，並且存在眾多與骨科相關的製藥公司。預計將佔據市場份額。 根據 Rural Health Information Hub 2020 報告，美國 65 歲及以上的人口超過 4600 萬，到 2050 年這一數字預計將增長到近 9000 萬。 此外，預計 2020 年至 2030 年間老年人口將增加近 1800 萬。 因此，由於骨關節炎和骨質疏鬆症等疾病的患病率增加，嚴重損害老年人的福祉，預計該國不斷增長的老年人口將推動研究目標市場的發展。

美國在北美地區的骨科生物材料市場佔有最大份額。 此外，美國醫療基礎設施的改善、醫療成本的上升以及運動損傷的高頻率正在推動市場增長。 同樣，2020 年 3 月，全國骨科和假肢促進協會 (NAAOP) 宣布，美國州和地方衛生官員應確保在大流行期間需要骨科和假肢護理的患者將繼續獲得醫療服務。他警告說，骨科和假肢和矯形器應被視為必須提供的基本服務。 這種發展導致該地區骨科手術的增加，在大流行階段增加了對生物材料的需求。

此外，監管部門的批准也在推動市場增長。 例如，2022 年 6 月，Ceramtech 的一種新型陶瓷全膝關節置換裝置獲得了美國食品和藥物管理局頒發的突破性裝置稱號。 此類批准正在推動市場增長。

因此，由於上述因素，該地區的市場預計會出現增長。

骨科生物材料市場競爭者分析

骨科生物材料市場競爭適中，由幾家大型企業組成。 目前主導市場的公司包括 Koninklijke DSM N.V.、Zimmer Biomet、Stryker、Invibio Ltd.、Evonik Industries、DePuy Synthes、Cam Bioceramics、Exactech, Inc 和 Globus Medical Inc。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 老年人口比例增加
    • 肌肉骨骼損傷的發生率增加
  • 市場製約因素
    • 保險報銷政策
  • 五力分析分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（金額基礎：百萬美元）

  • 按材料類型
    • 高分子材料
    • 陶瓷/生物活性玻璃
    • 磷酸鈣骨水泥
    • 金屬
    • 其他
  • 通過使用
    • 骨科
    • 關節成形術/重建
    • 關節內置換療法
    • 骨科植入物
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Koninklijke DSM N.V.
    • Zimmer Biomet
    • Stryker
    • Invibio Ltd.
    • Evonik Industries
    • DePuy Synthes
    • Cam Bioceramics
    • Exactech, Inc
    • Globus Medical Inc

第7章 市場機會與今後動向

簡介目錄
Product Code: 69676

The Orthopedic Biomaterials Market is expected to register a CAGR of 7.5% during the forecast period, 2022-2027.

Due to nationwide lockdowns in 2020, private and public transportation were restricted, resulting in fewer road accidents and injuries. As a result, the focus of the healthcare facilities switched from surgical procedures to COVID-19 patients, which had a short-term impact on the market in the initial pandemic phase, particularly in specialized hospitals. In addition, orthopedic centers and hospitals worldwide were closed or were operating with limited resources, while other hospitals were transformed into containment facilities and treatment units for COVID-19 patients. For instance, the research article published in August 2020, titled "Impact of COVID-19 on orthopedic surgery: Experience from Saudi Arabia", stated that orthopedic residency training was adversely affected by the COVID-19 pandemic. The inevitable pausing of all elective surgeries has limited hands-on practice and exposure to several procedures. Thus, such factors greatly impacted the demand for orthopedic biomaterials during the COVID-19 pandemic globally.

Moreover, the rising number of sports injuries, an increasing number of cases of trauma from accidents, and growing orthopedic surgeries like joint reconstruction and joint arthroplasty are also creating a massive demand for orthopedic biomaterials, thus driving the growth of the orthopedic biomaterial market.

The rising geriatric population, growing incidences of musculoskeletal injuries, and rising numbers of patients opting for knee replacement, construction, and other joint-related orthopedic procedures are expected to drive market growth. According to the United Nations Department of Economic and Social Affairs, World Ageing Population: 2020 Highlights, there were 727 million people aged 65 or older in 2020, which is expected to double and reach 1.5 billion by 2050. As the growing geriatric population worldwide is more susceptible to joint problems and ultimately surgeries, the adoption of orthopedic biomaterials is likely to increase over the coming years. Additionally, according to the World Health Organization's update of July 2022, approximately 1.71 billion people have musculoskeletal conditions worldwide. Such a high burden of musculoskeletal conditions results in increased musculoskeletal injuries, which in turn drives the growth of the market for orthopedic biomaterials.

Furthermore, the advancements in the field are also propelling the growth of the market. For instance, in September 2020, Evonik developed a new osteoconductive polyether ether ketone (PEEK) for the medical technology market that improves the fusion between bone and an implant.

Thus, the aforementioned factors are expected to boost the growth of the market throughout the analysis period. However, the lack of reimbursement policies associated with the procedures may hamper the market's growth to a certain extent.

Orthopedic Biomaterials Market Trends

The Ceramics & Bioactive Glasses Segment in Orthopedic biomaterial is Estimated to Witness a Healthy Growth in Future.

The ceramics & bioactive glasses segment by material type is estimated to witness healthy growth in the future. This is attributed to the increasing adoption of several spine surgeries and interbody fusion procedures. In addition, an increase in synthetic cages and pedicle screws during fixation procedures drives the segment growth. Synthetic cages and pedicle screws maintain stability in the target patient pool and increase allograft fusion rates.

Several in vitro and in vivo studies have evaluated the biocompatibility, biodegradability, and improved osseointegration of ceramics and bioactive glasses as orthopedic biomaterials. For instance, the article titled "Biomaterials in orthopaedics: the past and future with immune modulation" published in BMC (Part of Springer Nature) in February 2020, stated that while first-generation ceramics were accompanied by regular component damage, the second-generation bioinert ceramics, namely alumina augmented with zirconia, are extensively used in Korea and have almost replaced ultra-high molecular weight polyethylene (UHMWPE) as the material of choice in total hip arthroplasty. These materials are anticipated to be used constantly for joint replacement. Thus, higher efficiency of the ceramic and bioavailability of glass material in orthopedic procedures are expected to boost the segment's growth.

Additionally, in February 2022, Orthofix Medical launched a synthetic bioactive bone graft solution, Opus BA, a mix of carbonate apatite bone mineral, bioactive glass, and Type 1 collagen carrier for cervical and lumbar spine fusion procedures. Acting as a scaffold, Opus BA allows the bone to grow across the surface and is reabsorbed and replaced with a natural bone while healing. Such launches are propelling the growth of the market segment.

Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global orthopedic biomaterials market due to the increasing number of the target population, surge in the geriatric population, high adoption of advanced products associated with orthopedics, and the presence of a large number of pharmaceutical companies dealing in orthopedics. According to the Rural Health Information Hub 2020 report, in the United States, there are more than 46 million older adults aged 65 and up; by 2050, that number is expected to rise to nearly 90 million. The number of older adults is expected to increase by almost 18 million between 2020 and 2030. Thus, the rising geriatric population in the country is expected to boost the studied market due to the increasing prevalence of diseases like osteoarthritis and osteoporosis, which can seriously impair the well-being of elderly individuals.

The United States owns the largest share of the orthopedic biomaterials market in the North American region. Furthermore, well-established healthcare infrastructure, rising healthcare expenditure, and the high frequency of sports injuries in the United States fuel the market's growth. Likewise, in March 2020, the National Association for the Advancement of Orthotics and Prosthetics (NAAOP) issued an alert that state and local health authorities in the United States should consider orthopedic and prosthetic practices as an essential service that must remain accessible to patients in need of orthopedic and prosthetic care during the pandemic. Such developments have led to an increase in orthopedic surgical procedures within the region, thereby augmenting the demand for biomaterials during the pandemic phase.

Additionally, the approval from the regulatory authorities is also propelling the growth of the market. For instance, in June 2022, CeramTec received the United States Food and Drug Administration breakthrough device designation for a novel ceramic total knee replacement device. Such approvals are boosting the growth of the market.

Thus, owing to the abovementioned factors, the market is expected to show growth in the region.

Orthopedic Biomaterials Market Competitor Analysis

The orthopedic biomaterials market is moderately competitive and consists of several major players. Some companies currently dominating the market are Koninklijke DSM N.V., Zimmer Biomet, Stryker, Invibio Ltd., Evonik Industries, DePuy Synthes, Cam Bioceramics, Exactech, Inc., and Globus Medical Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Geriatric Population
    • 4.2.2 Growing Incidences of Musculoskeletal Injuries
  • 4.3 Market Restraints
    • 4.3.1 Reimbursement Policies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value-USD million)

  • 5.1 By Material Type
    • 5.1.1 Polymers
    • 5.1.2 Ceramics & Bioactive Glasses
    • 5.1.3 Calcium Phosphate Cements
    • 5.1.4 Metal
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Orthobiologics
    • 5.2.2 Joint Replacement/Reconstruction
    • 5.2.3 Viscosupplementation
    • 5.2.4 Orthopedic Implants
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke DSM N.V.
    • 6.1.2 Zimmer Biomet
    • 6.1.3 Stryker
    • 6.1.4 Invibio Ltd.
    • 6.1.5 Evonik Industries
    • 6.1.6 DePuy Synthes
    • 6.1.7 Cam Bioceramics
    • 6.1.8 Exactech, Inc
    • 6.1.9 Globus Medical Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS